These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37813295)

  • 1. Comprehensive split TEV based protein-protein interaction screening reveals TAOK2 as a key modulator of Hippo signalling to limit growth.
    Ma X; Mandausch FJ; Wu Y; Sahoo VK; Ma W; Leoni G; Hostiuc M; Wintgens JP; Qiu J; Kannaiyan N; Rossner MJ; Wehr MC
    Cell Signal; 2024 Jan; 113():110917. PubMed ID: 37813295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
    Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
    Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAP4K2 connects the Hippo pathway to autophagy in response to energy stress.
    Seo G; Mckinley J; Wang W
    Autophagy; 2024 Mar; 20(3):704-706. PubMed ID: 37937799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid kinase PIP5Kα contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1.
    Le TPH; Nguyen NTT; Le DDT; Anwar MA; Lee SY
    Cell Commun Signal; 2023 Jun; 21(1):149. PubMed ID: 37337213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-10 and -221 modulate differential expression of Hippo signaling pathway in human astroglial tumors.
    Aguennouz M; Polito F; Visalli M; Vita G; Raffa G; Oteri R; Ghazi B; Scalia G; Angileri FF; Barresi V; Caffo M; Cardali S; Conti A; Macaione V; Bartolotta M; Giorgio RD; Germanò A
    Cancer Treat Res Commun; 2020; 24():100203. PubMed ID: 32777750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells].
    Yan R; Liang ZW; Liu HS; Ge Y; An GY
    Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):594-604. PubMed ID: 37462016
    [No Abstract]   [Full Text] [Related]  

  • 7. SUMOylation of large tumor suppressor 1 at Lys751 attenuates its kinase activity and tumor-suppressor functions.
    Mei L; Yuan L; Shi W; Fan S; Tang C; Fan X; Yang W; Qian Y; Hussain M; Wu X
    Cancer Lett; 2017 Feb; 386():1-11. PubMed ID: 27847303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Hippo kinases control inflammatory Hippo signaling and restrict bacterial infection in phagocytes.
    St Louis BM; Quagliato SM; Su Y-T; Dyson G; Lee P-C
    mBio; 2024 May; 15(5):e0342923. PubMed ID: 38624208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMOylation activates large tumour suppressor 1 to maintain the tissue homeostasis during Hippo signalling.
    Mei L; Qv M; Bao H; He Q; Xu Y; Zhang Q; Shi W; Ren Q; Yan Z; Xu C; Tang C; Hussain M; Zeng LH; Wu X
    Oncogene; 2021 Sep; 40(35):5357-5366. PubMed ID: 34267330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The LKB1-TSSK1B axis controls YAP phosphorylation to regulate the Hippo-YAP pathway.
    Kim CL; Lim SB; Choi SH; Kim DH; Sim YE; Jo EH; Kim K; Lee K; Park HS; Lim SB; Kang LJ; Jeong HS; Lee Y; Hansen CG; Mo JS
    Cell Death Dis; 2024 Jan; 15(1):76. PubMed ID: 38245531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LATS1 K751 acetylation blocks activation of Hippo signalling and switches LATS1 from a tumor suppressor to an oncoprotein.
    Yang S; Xu W; Liu C; Jin J; Li X; Jiang Y; Zhang L; Meng X; Zhan J; Zhang H
    Sci China Life Sci; 2022 Jan; 65(1):129-141. PubMed ID: 33945069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1.
    Ji J; Ding K; Luo T; Xu R; Zhang X; Huang B; Chen A; Zhang D; Miletic H; Bjerkvig R; Thorsen F; Wang J; Li X
    Oncogene; 2020 Jan; 39(5):1125-1139. PubMed ID: 31605013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.
    Si Y; Ji X; Cao X; Dai X; Xu L; Zhao H; Guo X; Yan H; Zhang H; Zhu C; Zhou Q; Tang M; Xia Z; Li L; Cong YS; Ye S; Liang T; Feng XH; Zhao B
    Cancer Res; 2017 Sep; 77(18):4868-4880. PubMed ID: 28754671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the hippo signaling pathway in human gastric cancer.
    Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
    Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RASSF1A-Mediated Suppression of Estrogen Receptor Alpha (ERα)-Driven Breast Cancer Cell Growth Depends on the Hippo-Kinases LATS1 and 2.
    Roßwag S; Sleeman JP; Thaler S
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lats1 Deletion Causes Increased Germ Cell Apoptosis and Follicular Cysts in Mouse Ovaries.
    Sun T; Pepling ME; Diaz FJ
    Biol Reprod; 2015 Jul; 93(1):22. PubMed ID: 26040669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer.
    Schirmer AU; Driver LM; Zhao MT; Wells CI; Pickett JE; O'Bryne SN; Eduful BJ; Yang X; Howard L; You S; Devi GR; DiGiovanni J; Freedland SJ; Chi JT; Drewry DH; Macias E
    Mol Ther; 2022 Jan; 30(1):485-500. PubMed ID: 34450249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of LATS1 with SMAC links the MST2/Hippo pathway with apoptosis in an IAP-dependent manner.
    García-Gutiérrez L; Fallahi E; Aboud N; Quinn N; Matallanas D
    Cell Death Dis; 2022 Aug; 13(8):692. PubMed ID: 35941108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase-mediated inhibitory phosphorylation of the transcriptional coactivator YAP.
    Thines L; Gorisse L; Li Z; Sayedyahossein S; Sacks DB
    J Biol Chem; 2022 May; 298(5):101839. PubMed ID: 35307353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T851I mutation of human large tumor suppressor 1 disrupts its kinase activity and tumor-suppressor functions.
    Zhang Q; Du X; He Q; Shi W; Mei L; Qv M; Tan D; Wu J; Zeng LH; Wu X
    Life Sci; 2021 Jan; 264():118655. PubMed ID: 33141042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.